Hot Prescriber Trend: GLP-1 Utilizers in Obesity Treatment Shifting to Phentermine Scripta Jun 21, 2024 2 min read Updated: Jun 24, 2024 Thanks to clinical trials that demonstrated a 12% weight-loss(1) and much buzzed about appetite-suppressing effects, the GLP-1 weight loss medications Wegovy and Zepbound, has been all over the news, and so has its high price tag
hence, GLP-1 agonists could be started in primary or secondary care
Some users describe feeling almost indifferent toward foods that once triggered powerful cravings
These FDA-approved options are backed by extensive clinical evidence, making them safer and more predictable for long-term weight management
What is the cost difference between PlexusDx compounded GLP-1s and what Ro or Orderly Meds offer
doi: 10.1093/EURHEARTJ/EHAA082 119 BatistaAFBodart-SantosVDe FeliceFGFerreiraST